|
MED27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.726200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.822600E-01 |
| Normal-vs-Stage2 |
7.197800E-01 |
| Normal-vs-Stage3 |
8.583800E-01 |
| Normal-vs-Stage4 |
9.000400E-01 |
| Stage1-vs-Stage2 |
7.478000E-01 |
| Stage1-vs-Stage3 |
8.432400E-01 |
| Stage1-vs-Stage4 |
9.254400E-01 |
| Stage2-vs-Stage3 |
6.490400E-01 |
| Stage2-vs-Stage4 |
8.881600E-01 |
| Stage3-vs-Stage4 |
8.241600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.636600E-01 |
| Normal-vs-AfricanAmerican |
3.407000E-01 |
| Normal-vs-Asian |
2.604000E-01 |
| Caucasian-vs-AfricanAmerican |
1.097350E-01 |
| Caucasian-vs-Asian |
4.181600E-01 |
| AfricanAmerican-vs-Asian |
1.735020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.495000E-01 |
| Normal-vs-Female |
5.442800E-01 |
| Male-vs-Female |
2.998400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.928200E-01 |
| Normal-vs-Extreme_Weight |
5.512400E-01 |
| Normal-vs-Obese |
5.454000E-01 |
| Normal-vs-Extreme_Obese |
3.300000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.169000E-01 |
| Normal_Weight-vs-Obese |
8.643800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.406400E-01 |
| Extreme_Weight-vs-Obese |
9.194200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.664200E-01 |
| Obese-vs-Extreme_Obese |
3.242000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.983000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.956400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.251200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.998610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.594000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.733600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.172200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.176000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.807400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.706600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.728400E-01 |
| Normal-VS-Type2 PRCC |
7.677600E-02 |
| Normal-VS-KIRP CIMP |
6.394400E-01 |
| Normal-VS-Unclassified PRCC |
1.982160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.90320000000344E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.822000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.639100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.952600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.292400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.746200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.369800E-01 |
| Normal-vs-N1 |
9.350800E-01 |
| Normal-vs-N2 |
8.904400E-01 |
| N0-vs-N1 |
3.352200E-01 |
| N0-vs-N2 |
8.279200E-01 |
| N1-vs-N2 |
9.065200E-01 |
|
|
